Phase II study of Troxatyl ™ in patients with chronic myeloid leukemia in blastic phase (CML-BP).

被引：0
|
作者：
Giles, F
Feldman, E
Cortes, J
Faderl, S
Larson, R
Mamus, S
Thomas, D
Garcia-Manero, G
O'Brien, S
Beran, M
Talpaz, M
Kantarjian, H
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cornell Univ, New York, NY USA
[3] Univ Chicago, Canc Res Ctr, Chicago, IL USA
[4] Univ Texas, MD Anderson Canc Ctr, Orlando, FL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4764
引用
收藏
页码：258B / 258B
页数：1
相关论文
共 50 条
  • [1] Troxatyl™ plus topotecan, ara-C, or idarubicin in patients (pts) with refractory acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or blastic-phase chronic myeloid leukemia (CML-BP):: A randomized Phase I/II study.
    Giles, FJ
    Faderl, S
    Thomas, DA
    Cortes, J
    Jeha, SS
    Garcia-Manero, G
    Douer, D
    Levine, AM
    Estey, EH
    Beran, M
    O'Brien, S
    Koller, C
    Andreeff, M
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 594A - 594A
  • [2] Phase II study of decitabine in combination with imatinib mesylate in patients with accelerated (AP) or blastic phase (BP) of chronic myeloid leukemia (CML).
    Oki, Y
    Kantarjian, HM
    O'Brien, S
    Verstovsek, S
    Gharibyan, V
    Cortes, J
    Morris, GM
    Garcia-Manero, G
    Issa, JP
    BLOOD, 2005, 106 (11) : 320A - 320A
  • [3] OUTCOME OF BLAST PHASE CHRONIC MYELOID LEUKEMIA (CML-BP) IN THE TYROSINE KINASE INHIBITOR ERA
    Talati, C.
    Isenalumhe, L.
    Shams, S.
    Kuykendall, A.
    Chavez, J.
    Shah, B.
    Sweet, K.
    Pinilla-Ibarz, J.
    HAEMATOLOGICA, 2017, 102 : 239 - 239
  • [4] Troxatyl™ (troxacitabine) has activity in blastic phase chronic myeloid leukemia (CMLBP).
    Giles, FJ
    Cortes, JE
    Bivins, C
    Andreeff, M
    Talpaz, M
    Jolivet, J
    Kantarjian, HM
    BLOOD, 2000, 96 (11) : 254B - 254B
  • [5] MEGAKARYOCYTIC BLASTIC PHASE (BP) OF CHRONIC MYELOID LEUKEMIA (CML) - A SINGLE INSTITUTION EXPERIENCE
    Baljevic, M.
    Kantarjian, H.
    Al Amen, A.
    Ravandi, F.
    Borthakur, G.
    Quintas-Cardama, A.
    Jabbour, E.
    Pierce, S.
    Cortes, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 348 - 349
  • [6] A phase I/II trial of increasing doses of mitoxantrone with fludarabine and cytarabine (FAM regimen) in relapsed acute leukemia and chronic myelogeneous leukemia in blastic phase (CML-BP).
    Koller, CA
    Kantarjian, H
    Feldman, E
    Estey, E
    OBrien, S
    Rios, MB
    Keating, M
    BLOOD, 1997, 90 (10) : 3834 - 3834
  • [7] Single Centre, Retrospective Analysis of Treatment Outcomes and Prognostic Factors in Blastic Phase Chronic Myeloid Leukemia (CML-BP) Following Systemic Therapy
    Tang, Kenny
    Maze, Dawn
    Yee, Karen
    Sibai, Hassan
    Davidson, Marta B.
    Chan, Steven M.
    Schimmer, Aaron D.
    Schuh, Andre C.
    Bankar, Aniket
    Richard-Carpentier, Guillaume
    Tierens, Anne
    Minden, Mark D.
    Gupta, Vikas
    Lipton, Jeffrey H.
    Kim, Dennis
    BLOOD, 2022, 140 : 9608 - 9609
  • [8] Isolated Extramedullary (EMD) Blastic Transformation of Chronic Myeloid Leukemia (CML-BP) in the TKI Era: Characteristics, Treatments and Outcomes
    Ghorab, Ahmad
    Jain, Preetesh
    Kantarjian, Hagop M.
    Kanagal-Shamanna, Rashmi
    Jabbour, Elias J.
    Sasaki, Koji
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Bose, Prithviraj
    Yilmaz, Musa
    Naqvi, Kiran
    Wierda, William G.
    Verstovsek, Srdan
    Jain, Nitin
    Estrov, Zeev
    Ravandi, Farhad
    O'Brien, Susan M.
    Cortes, Jorge E.
    BLOOD, 2017, 130
  • [9] CHROMOSOMAL FINDINGS IN RELATION TO BLASTIC PHASE OF CHRONIC MYELOID-LEUKEMIA (CML)
    SANDBERG, AA
    SONTA, S
    BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE, 1978, 57 (03): : 334 - 343
  • [10] POLIMELPHALAN (PEPTICHEMIO) (PTC) IN BLASTIC CRISIS (BC) OF CHRONIC MYELOID-LEUKEMIA (CML)-PHASE-II STUDY
    CARTEI, G
    DANIELE, G
    PACCAGNELLA, A
    FORNASIERO, A
    FIORENTINO, MV
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 122 - 122
12345